HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
G Nishimura Selected Research
G Nishimura Research Topics
Disease
9
Neoplasms (Cancer)
01/2013 - 03/2000
7
Neoplasm Metastasis (Metastasis)
07/2002 - 02/2000
5
Carcinoma (Carcinomatosis)
10/2001 - 03/2000
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2013 - 07/2000
3
Pancreatic Neoplasms (Pancreatic Cancer)
10/2001 - 12/2000
2
Strudwick syndrome
12/2011 - 02/2001
2
Stomach Neoplasms (Stomach Cancer)
07/2002 - 02/2000
2
Head and Neck Neoplasms (Head and Neck Cancer)
10/2001 - 07/2000
2
Squamous Cell Carcinoma of Head and Neck
10/2000 - 05/2000
1
Type V Osteogenesis Imperfecta
12/2021
1
Osteoporosis
12/2021
1
Colonic Neoplasms (Colon Cancer)
11/2015
1
Metatropic dwarfism
10/2010
1
Brachyolmia
10/2010
1
Kozlowski type Spondylometaphyseal dysplasia
10/2010
1
Congenital Abnormalities (Deformity)
01/2010
1
Scoliosis
01/2010
1
Colorectal Neoplasms (Colorectal Cancer)
10/2001
1
Rectal Neoplasms (Rectal Cancer)
10/2001
1
Myeloid Leukemia (Leukemia, Myelocytic)
09/2001
1
Alcoholic Fatty Liver
03/2001
1
Fatty Liver
03/2001
1
Pyle disease
02/2001
1
Madelung Deformity
01/2001
1
Alopecia (Baldness)
10/2000
1
Cataract (Cataracts)
10/2000
1
Chondrodysplasia Punctata (Stippled Epiphyses)
10/2000
1
Ichthyosis (Xeroderma)
10/2000
1
Islet Cell Carcinoma
10/2000
1
Stomach Ulcer (Gastric Ulcer)
10/2000
1
Herpes Simplex
05/2000
1
Carcinogenesis
03/2000
1
Esophageal Squamous Cell Carcinoma
03/2000
Drug/Important Bio-Agent (IBA)
2
Tegafur
IBA
11/2015 - 10/2001
2
Uracil
IBA
11/2015 - 10/2000
2
O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)
IBA
10/2001 - 07/2000
2
Angiogenesis Inhibitors
IBA
10/2001 - 07/2000
2
Fluorouracil (Carac)
FDA Link
Generic
10/2000 - 10/2000
2
Therapeutic Uses
IBA
10/2000 - 05/2000
1
Sphingomyelins
IBA
12/2021
1
ceramide cholinephosphotransferase
IBA
12/2021
1
5' Untranslated Regions (5' UTR)
IBA
12/2021
1
Proteins (Proteins, Gene)
FDA Link
12/2021
1
Leucovorin (Folinic Acid)
FDA Link
11/2015
1
Collagen Type II (Type II Collagen)
IBA
12/2011
1
Cations
IBA
10/2010
1
Interleukin-8 (Interleukin 8)
IBA
10/2001
1
Potassium
IBA
10/2001
1
titanium silicide (TS-1)
IBA
10/2001
1
fumagillol
IBA
10/2001
1
fumagillin
IBA
10/2001
1
Cytochromes c (Cytochrome c)
IBA
09/2001
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2001
1
S100 Calcium-Binding Protein A4
IBA
04/2001
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
03/2001
1
Endotoxins
IBA
03/2001
1
Collagen Type X
IBA
02/2001
1
Fas Ligand Protein (Fas Ligand)
IBA
01/2001
1
fas Receptor (CD95 Antigen)
IBA
01/2001
1
Differentiation Antigens
IBA
12/2000
1
2,4-thiazolidinedione (thiazolidinedione)
IBA
12/2000
1
Ligands
IBA
12/2000
1
PPAR gamma
IBA
12/2000
1
Probucol (Lorelco)
FDA Link
11/2000
1
tiracoxib
IBA
11/2000
1
potassium oxonate
IBA
10/2000
1
Cytidine Diphosphate (CDP)
IBA
10/2000
1
Cisplatin (Platino)
FDA Link
Generic
07/2000
1
Antibodies
IBA
05/2000
1
Interferon-gamma (Interferon, gamma)
IBA
05/2000
1
asialo GM1 ganglioside
IBA
05/2000
1
Cancer Vaccines
IBA
05/2000
1
Interleukin-2 (IL2)
IBA
05/2000
1
Cadherins (E-Cadherin)
IBA
03/2000
1
beta Catenin
IBA
03/2000
1
Catenins
IBA
03/2000
1
alpha Catenin (alpha E-Catenin)
IBA
03/2000
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
01/2013 - 02/2000
4
Therapeutics
10/2001 - 02/2000
2
Radiotherapy
01/2013 - 01/2010
2
Combination Drug Therapy (Combination Chemotherapy)
10/2001 - 02/2000
2
Hepatectomy
10/2000 - 10/2000
1
Adjuvant Chemotherapy
11/2015
1
Duration of Therapy
11/2015
1
Laryngectomy
01/2013
1
Nephrectomy
01/2010
1
Laparotomy
07/2002
1
Oral Administration
10/2001
1
Immunotherapy
05/2000
1
Neoadjuvant Therapy
02/2000